160 related articles for article (PubMed ID: 36937431)
1. FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration.
Li CM; Zhang J; Wu W; Zhu Z; Li F; Wu D; Wang XJ; Xie CM; Gong JP
Front Oncol; 2023; 13():1138348. PubMed ID: 36937431
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on tumor cell proliferation, migration and invasion.
Ma R; Liu W; Sun T; Dang C; Li K
PeerJ; 2023; 11():e15373. PubMed ID: 37250703
[TBL] [Abstract][Full Text] [Related]
3. Association between F-box-only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosis.
Wu S; Qin L; Yang J; Wang J; Shen Y
Cancer Med; 2023 Apr; 12(8):10062-10076. PubMed ID: 36710413
[TBL] [Abstract][Full Text] [Related]
4. FNBP4 is a Potential Biomarker Associated with Cuproptosis and Promotes Tumor Progression in Hepatocellular Carcinoma.
Zheng KW; Zhang CH; Wu W; Zhu Z; Gong JP; Li CM
Int J Gen Med; 2023; 16():467-480. PubMed ID: 36760683
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis.
Maimaiti Y; Kamali A; Yang P; Zhong K; Abuduhadeer X
Protein Pept Lett; 2022; 29(7):595-604. PubMed ID: 35899951
[TBL] [Abstract][Full Text] [Related]
6. F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.
Zhou H; Zeng C; Liu J; Luo H; Huang W
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765911
[TBL] [Abstract][Full Text] [Related]
7. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Xu M; Sun L; Wang L; Yao B; Li Q; Yang W; Tu K; Liu Q
Theranostics; 2018; 8(17):4649-4663. PubMed ID: 30279729
[No Abstract] [Full Text] [Related]
9. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
[TBL] [Abstract][Full Text] [Related]
10. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
11. AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway.
Tian K; Deng Y; Li Z; Zhou H; Yao H
Oncol Lett; 2024 Jan; 27(1):18. PubMed ID: 38034486
[TBL] [Abstract][Full Text] [Related]
12. RAB18 promotes proliferation and metastasis in hepatocellular carcinoma.
Gong T; Zhou B; Liu M; Chen X; Huang S; Xu Y; Luo R; Chen Z
Am J Transl Res; 2019; 11(2):1009-1019. PubMed ID: 30899400
[TBL] [Abstract][Full Text] [Related]
13. ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma.
Ma XL; Nie YY; Xie SH; Zheng H; Tong Y; Wang YC; Yan TQ; Meng X; Cao JZ; Tang WG; Guo L; Lu RQ
Exp Hematol Oncol; 2023 Apr; 12(1):38. PubMed ID: 37061723
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
15. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
16. CircRNA Circ-CCND1 Aggravates Hepatocellular Carcinoma Tumorigenesis by Regulating the miR-497-5p/HMGA2 Axis.
Zheng S; Hou J; Chang Y; Zhao D; Yang H; Yang J
Mol Biotechnol; 2022 Feb; 64(2):178-186. PubMed ID: 34564768
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway.
Yao B; Li Y; Chen T; Niu Y; Wang Y; Yang Y; Wei X; Liu Q; Tu K
Clin Transl Med; 2021 Mar; 11(3):e366. PubMed ID: 33784016
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the FBXO43 gene inhibits tumor growth in human breast cancer by limiting its interaction with PCNA.
Ma R; Zhu K; Yuan D; Gong M; Li Y; Li K; Meng L
J Transl Med; 2021 Oct; 19(1):425. PubMed ID: 34645483
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
